| Jay Chudow, MD | |
|
111 E 210th St Fl 2, Bronx, NY 10467-2401 | |
| (917) 886-5972 | |
| Not Available |
| Full Name | Jay Chudow |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 8 Years |
| Location | 111 E 210th St Fl 2, Bronx, New York |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669828075 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 314267-01 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Montefiore Medical Center | Bronx, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Montefiore Medical Center | 3779496021 | 2003 |
News Archive
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
Scientists have developed an easy-to-use computer program that can quickly analyse bacterial DNA from a patient's infection and predict which antibiotics will work, and which will fail due to drug resistance. The software is currently being trialled in three UK hospitals to see whether it could help speed up diagnosis of drug-resistant infections and enable doctors to better target the prescription of antibiotics.
AbbVie, Teneobio, Inc. and its affiliate TeneoOne, Inc. announced today that they have entered a global strategic transaction to develop and commercialize TNB-383B, a BCMA-targeting immunotherapeutic for the potential treatment of multiple myeloma.
More than 120 professionals from the field of health and other experts from thirty-three countries worldwide have taken part in the social awareness event of the EUDONORGAN project, an initiative directly launched by the European Parliament and led by the University of Barcelona, together with the Bosch i Gimpera Foundation and the DTI - TPM Foundation, located at the Barcelona Science Park.
The breast screening programme...is making a real difference to over a million women by giving them peace of mind that they are being checked for this disease every three years."
› Verified 7 days ago
| Entity Name | Montefiore Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063525152 PECOS PAC ID: 3779496021 Enrollment ID: O20031113000235 |
News Archive
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
Scientists have developed an easy-to-use computer program that can quickly analyse bacterial DNA from a patient's infection and predict which antibiotics will work, and which will fail due to drug resistance. The software is currently being trialled in three UK hospitals to see whether it could help speed up diagnosis of drug-resistant infections and enable doctors to better target the prescription of antibiotics.
AbbVie, Teneobio, Inc. and its affiliate TeneoOne, Inc. announced today that they have entered a global strategic transaction to develop and commercialize TNB-383B, a BCMA-targeting immunotherapeutic for the potential treatment of multiple myeloma.
More than 120 professionals from the field of health and other experts from thirty-three countries worldwide have taken part in the social awareness event of the EUDONORGAN project, an initiative directly launched by the European Parliament and led by the University of Barcelona, together with the Bosch i Gimpera Foundation and the DTI - TPM Foundation, located at the Barcelona Science Park.
The breast screening programme...is making a real difference to over a million women by giving them peace of mind that they are being checked for this disease every three years."
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jay Chudow, MD 111 E 210th St Fl 2, Bronx, NY 10467-2401 Ph: (718) 920-5949 | Jay Chudow, MD 111 E 210th St Fl 2, Bronx, NY 10467-2401 Ph: (917) 886-5972 |
News Archive
Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp., announced today that its latest joint venture target, Amarantus BioSciences, Inc., expects to announce the results of a preclinical study evaluating the potential of its new protein therapy as a treatment for Traumatic Brain Injury (TBI).
Scientists have developed an easy-to-use computer program that can quickly analyse bacterial DNA from a patient's infection and predict which antibiotics will work, and which will fail due to drug resistance. The software is currently being trialled in three UK hospitals to see whether it could help speed up diagnosis of drug-resistant infections and enable doctors to better target the prescription of antibiotics.
AbbVie, Teneobio, Inc. and its affiliate TeneoOne, Inc. announced today that they have entered a global strategic transaction to develop and commercialize TNB-383B, a BCMA-targeting immunotherapeutic for the potential treatment of multiple myeloma.
More than 120 professionals from the field of health and other experts from thirty-three countries worldwide have taken part in the social awareness event of the EUDONORGAN project, an initiative directly launched by the European Parliament and led by the University of Barcelona, together with the Bosch i Gimpera Foundation and the DTI - TPM Foundation, located at the Barcelona Science Park.
The breast screening programme...is making a real difference to over a million women by giving them peace of mind that they are being checked for this disease every three years."
› Verified 7 days ago
Selina Sultana Zaman, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 718-920-9000 | |
Dr. Jyothi B Kudakandira, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1650 Grand Concourse, Bronx, NY 10457 Phone: 718-960-1234 | |
Mana Rao, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Dr. Keshav Teelucksingh, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Tannaz Iranpour Boroujeni, M.D Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 600 E 233rd St, Bronx, NY 10466 Phone: 617-840-0110 | |
Heather Root, MD Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 718-920-8592 Fax: 718-405-0610 | |
Benjamin Tuttle Hayes, MD Cardiovascular Disease Medicare: May Accept Medicare Assignments Practice Location: 305 E 161st St, Bronx, NY 10451 Phone: 718-579-2500 Fax: 718-579-2599 |